Switch to
More onapp

How to use scorecard? Learn more

Shilpa Medicare Ltd

SHILPAMED
Health CarePharmaceuticals
SmallcapWith a market cap of ₹8,190 cr, stock is ranked 627
High RiskStock is 3.59x as volatile as Nifty
815.154.35 (-0.53%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹8,190 cr, stock is ranked 627
High RiskStock is 3.59x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
134.07
PB RatioPB Ratio
4.55
Dividend YieldDiv. Yield
Sector PESector PE
51.53
Sector PBSector PB
6.56
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation.

Investor PresentationView older 

Nov 13, 2024

PDF
View Older Presentations

Financial TrendFinancial statements 

20212022202320240.991.171.071.170.150.06-0.030.03
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 5.68%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

General Updates 
Announced OnNov 27, 2024

USFDA Approval of NDA IMKELDI (Imatinib Oral Solution) Filled by our partner Shorla Oncology developed by our JV Oncosol Limited | Download

USFDA Approval of NDA IMKELDI (Imatinib Oral Solution) Filled by our partner Shorla Oncology developed by our JV Oncosol Limited | Download

General Updates 
Announced OnNov 26, 2024

Indian Regulatory Authority - SEC approval for conducting Phase III Clinical trials for Recombinant Human Albumin (rHA) 20% | Download

Indian Regulatory Authority - SEC approval for conducting Phase III Clinical trials for Recombinant Human Albumin (rHA) 20% | Download

Cash Dividend 
Ex. DateSep 19, 2022

Final • Div/Share: ₹ 1.1

See all events